Creative Biolabs Enhances Single-Cell Multi-Omics and RNA Sequencing for Advanced Biomedical Discovery

Creative Biolabs has significantly expanded its comprehensive suite of single-cell analytical solutions to meet the growing demand for high-resolution cellular profiling. By integrating advanced single-cell RNA sequencing with robust multi-omics workflows, the company empowers researchers in oncology, immunology, and neuroscience to dissect cellular heterogeneity with precision. These refined services enable the identification of rare cell subpopulations and the characterization of complex tumor microenvironments, facilitating breakthroughs in clinical research and therapeutic development.

To address challenges associated with fragile or archival samples, the platform now features specialized single-nucleus RNA sequencing (snRNA-seq). This optimized approach bypasses the limitations of traditional enzymatic dissociation, allowing for the accurate analysis of flash-frozen biopsies, myocardium, and neural tissues. By isolating intact nuclei, researchers can preserve high-quality RNA profiles while minimizing stress-induced artifacts, ensuring the integrity of data derived from even the most difficult biological specimens.

Furthermore, the upgraded multi-omics platform enables the simultaneous interrogation of genomic, epigenomic, and proteomic layers within individual cells. By linking chromatin accessibility and surface protein expression to transcriptomic data, Creative Biolabs provides a holistic view of cellular identity. Supported by cutting-edge microfluidics and tailored bioinformatics pipelines, this modular ecosystem helps global biopharmaceutical partners construct multi-dimensional cellular atlases to accelerate target discovery and precision medicine initiatives.